345 related articles for article (PubMed ID: 34623753)
1. Metal-Polyphenol-Network Coated Prussian Blue Nanoparticles for Synergistic Ferroptosis and Apoptosis via Triggered GPX4 Inhibition and Concurrent In Situ Bleomycin Toxification.
Zhou L; Chen J; Li R; Wei L; Xiong H; Wang C; Chai K; Chen M; Zhu Z; Yao T; Lin Y; Dong C; Shi S
Small; 2021 Nov; 17(47):e2103919. PubMed ID: 34623753
[TBL] [Abstract][Full Text] [Related]
2. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
3. Photothermal nanozyme-ignited Fenton reaction-independent ferroptosis for breast cancer therapy.
Xing L; Liu XY; Zhou TJ; Wan X; Wang Y; Jiang HL
J Control Release; 2021 Nov; 339():14-26. PubMed ID: 34547257
[TBL] [Abstract][Full Text] [Related]
4. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
[TBL] [Abstract][Full Text] [Related]
5. Boosting ferroptosis and microtubule inhibition for antitumor therapy via a carrier-free supermolecule nanoreactor.
Mu M; Liang X; Zhao N; Chuan D; Chen B; Zhao S; Wang G; Fan R; Zou B; Han B; Guo G
J Pharm Anal; 2023 Jan; 13(1):99-109. PubMed ID: 36816538
[TBL] [Abstract][Full Text] [Related]
6. Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy.
Li K; Lin C; Li M; Xu K; He Y; Mao Y; Lu L; Geng W; Li X; Luo Z; Cai K
ACS Nano; 2022 Feb; 16(2):2381-2398. PubMed ID: 35041395
[TBL] [Abstract][Full Text] [Related]
7. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
8. Amplified Fenton-Based Oxidative Stress Utilizing Ultraviolet Upconversion Luminescence-Fueled Nanoreactors for Apoptosis-Strengthened Ferroptosis Anticancer Therapy.
Nguyen NT; Kim J; Le XT; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
ACS Nano; 2023 Jan; 17(1):382-401. PubMed ID: 36579941
[TBL] [Abstract][Full Text] [Related]
9. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells.
Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W
Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
[TBL] [Abstract][Full Text] [Related]
11. A glutathione-responsive polyphenol - Constructed nanodevice for double roles in apoptosis and ferroptosis.
Chen H; Yan Z; Wu S; Li F
Colloids Surf B Biointerfaces; 2021 Sep; 205():111902. PubMed ID: 34107442
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.
Zhang Y; Fu X; Jia J; Wikerholmen T; Xi K; Kong Y; Wang J; Chen H; Ma Y; Li Z; Wang C; Qi Q; Thorsen F; Wang J; Cui J; Li X; Ni S
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43408-43421. PubMed ID: 32885649
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional "ball-rod" Janus nanoparticles boosting Fenton reaction for ferroptosis therapy of non-small cell lung cancer.
Zhu G; Chi H; Liu M; Yin Y; Diao H; Liu Z; Guo Z; Xu W; Xu J; Cui C; Xing XJ; Ma K
J Colloid Interface Sci; 2022 Sep; 621():12-23. PubMed ID: 35447518
[TBL] [Abstract][Full Text] [Related]
14. Upconverting Nanocarriers Enable Triggered Microtubule Inhibition and Concurrent Ferroptosis Induction for Selective Treatment of Triple-Negative Breast Cancer.
Zhu J; Dai P; Liu F; Li Y; Qin Y; Yang Q; Tian R; Fan A; Medeiros SF; Wang Z; Zhao Y
Nano Lett; 2020 Sep; 20(9):6235-6245. PubMed ID: 32804509
[TBL] [Abstract][Full Text] [Related]
15. Ferrous-Supply-Regeneration Nanoengineering for Cancer-Cell-Specific Ferroptosis in Combination with Imaging-Guided Photodynamic Therapy.
Liu T; Liu W; Zhang M; Yu W; Gao F; Li C; Wang SB; Feng J; Zhang XZ
ACS Nano; 2018 Dec; 12(12):12181-12192. PubMed ID: 30458111
[TBL] [Abstract][Full Text] [Related]
16. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy.
Yu M; Yu J; Yi Y; Chen T; Yu L; Zeng W; Ouyang XK; Huang C; Sun S; Wang Y; Liu Y; Lin C; Wu M; Mei L
J Control Release; 2022 Jul; 347():104-114. PubMed ID: 35513212
[TBL] [Abstract][Full Text] [Related]
18. A Multifunctional Liposome for Synergistic Chemotherapy with Ferroptosis Activation of Triple-Negative Breast Cancer.
Chai J; Hu J; Wang T; Bao X; Luan J; Wang Y
Mol Pharm; 2024 Feb; 21(2):781-790. PubMed ID: 38153044
[TBL] [Abstract][Full Text] [Related]
19. Triggered All-Active Metal Organic Framework: Ferroptosis Machinery Contributes to the Apoptotic Photodynamic Antitumor Therapy.
Meng X; Deng J; Liu F; Guo T; Liu M; Dai P; Fan A; Wang Z; Zhao Y
Nano Lett; 2019 Nov; 19(11):7866-7876. PubMed ID: 31594301
[TBL] [Abstract][Full Text] [Related]
20. Metal ions/nucleotide coordinated nanoparticles comprehensively suppress tumor by synergizing ferroptosis with energy metabolism interference.
Wang Y; Chen J; Lu J; Xi J; Xu Z; Fan L; Dai H; Gao L
J Nanobiotechnology; 2022 Apr; 20(1):199. PubMed ID: 35473696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
